Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Current Taxes (2022 - 2024)

Arcturus Therapeutics Holdings' Current Taxes history spans 3 years, with the latest figure at $979000.0 for Q1 2024.

  • For Q1 2024, Current Taxes fell 29.97% year-over-year to $979000.0; the TTM value through Mar 2024 reached $979000.0, down 29.97%, while the annual FY2023 figure was $641000.0, 50.5% down from the prior year.
  • Current Taxes reached $979000.0 in Q1 2024 per ARCT's latest filing, up from $641000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $1.4 million in Q1 2023 to a low of $482000.0 in Q3 2023.
  • Average Current Taxes over 3 years is $959000.0, with a median of $979000.0 recorded in 2024.
  • Peak YoY movement for Current Taxes: tumbled 50.5% in 2023, then dropped 29.97% in 2024.
  • A 3-year view of Current Taxes shows it stood at $1.3 million in 2022, then crashed by 50.5% to $641000.0 in 2023, then skyrocketed by 52.73% to $979000.0 in 2024.
  • Per Business Quant, the three most recent readings for ARCT's Current Taxes are $979000.0 (Q1 2024), $641000.0 (Q4 2023), and $482000.0 (Q3 2023).